Tafamidis treatment is associated with a significant reduction in ischemic stroke risk among patients with ATTR-CM and atrial fibrillation.

TNKase is administered as a single intravenous bolus over 5 seconds. The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The study examined 352 individuals with stroke ...

New York, USA, March 02, 2026 (GLOBE NEWSWIRE) -- Acute Ischemic Stroke Market Poised for Expansion During the Forecast Period (2026–2036) as Innovative Treatment Modalities Gain Momentum | ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed no difference in 3-month functional outcomes or mortality among patients with acute ...

For acute ischemic stroke within 48 hours of onset, the novel sublingual combination of edaravone (Radicava) with dexborneol appeared to dramatically improve functional outcomes in the phase III TASTE ...

PARIS--(BUSINESS WIRE)--Sensome, the pioneer of microsensing technology for instant intra-operative tissue analysis, today announced positive results from its first-in-human CLOT OUT clinical trial ...

Share on Pinterest Adding blood thinners to clot-busting medication after a stroke does not appear to improve the outcomes, according to a new study. credit: szjphoto/Getty Images. About 15 million ...